BSX News and Press, Boston Scientific Corporation From 05/18/24

MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints PR Newswire Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker ...

2024-05-15 14:20:39 ET Summary This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores in both value and quality. Invesco S&P 50...

Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors PR Newswire MARLBOROUGH, Mass. , May 8, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immedi...

2024-05-07 16:35:22 ET Billionaire hedge fund manager Steve Cohen, who is the founder of Point72 Asset Management, has let go of at least seven long-short equity portfolio managers, according to a report by Business Insider.... Read the full article on Seeking Alpha For further ...

2024-05-07 09:01:37 ET Apple ( NASDAQ: AAPL ) recently updated its capital return plan by adding a $110B to its buyback program. According to data highlighted by Mizuho, this massive buyback program is larger than 84% of the stocks that sit inside the S&P 500.... Read ...

2024-05-04 06:15:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many Wall Street investors keep a close eye on the opinions of major brokerages, such as Citigroup (NYSE: C ). Therefore, today we’ll explore three promising growth...

2024-04-26 07:15:03 ET Barclays analyst issues OVERWEIGHT recommendation for BSX on April 26, 2024 05:04AM ET. The previous analyst recommendation was Overweight. BSX was trading at $73.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...

2024-04-25 08:15:07 ET Citigroup analyst issues BUY recommendation for BSX on April 25, 2024 06:47AM ET. The previous analyst recommendation was Buy. BSX was trading at $72.91 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...

2024-04-25 07:00:07 ET Lawrence Biegelsen from Wells Fargo issued a price target of $82.00 for BSX on 2024-04-25 05:23:00. The adjusted price target was set to $82.00. At the time of the announcement, BSX was trading at $72.91. The overall price target consensus is at $6...

2024-04-24 18:15:02 ET Deutsche Bank analyst issues HOLD recommendation for BSX on April 24, 2024 04:20PM ET. The previous analyst recommendation was Hold. BSX was trading at $72.91 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...